CIK: 1283290 - Address: C/O Boundless Bio, Inc., 9880 Campus Point Drive, Suite 120, San Diego, CA 92121
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret111132-7-13-27-34-13
S%wins273673919110070

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/24/08 18:20
3/20/08
HALOHalozyme Therapeutics IncDEHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-1,5156.063-250-27680D106-24-280191923530-6-13-914-33
12/4/07 16:26
11/30/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1658.244-20-3700D317161-30-24-17-20-75-2-9-24-23-55
11/2/07 16:25
10/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-2269.032-25-3700D392213-1413-3-4-4-51-1-17-31-44-48
10/2/07 16:03
9/28/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-2208.785-25-4673D34425910-760-3-1-4-23-20-30-17
8/31/07 20:11
8/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-1138.822-13-2673D3172113-20-110-1-21332-8-42-12
8/31/07 20:07
8/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1058.572-12-2686D3172113-20-110-1-21332-8-42-12
8/2/07 16:16
7/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1648.203-20-3673D3712426-22-20-20-14-5-610011-35-4
7/2/07 10:39
6/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-799.596-8-1673D4162691215-12-10-8257-13-6-23-42
7/2/07 10:38
6/29/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-1589.436-17-2682D4162691215-12-10-8257-13-6-23-42
6/1/07 18:24
5/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS-6210.593-6-1577D4003172602512-2-3-111-12-19-23-52
6/1/07 18:21
5/31/07
HALOHalozyme Therapeutics IncNVHealthBioPrdBiological Products, (No DiagLim Jonathan ECADOP,CEOS.d-19810.353-19-3583D4003172602512-2-3-111-12-19-23-52

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact